SCHEMBL6660434

SCHEMBL6660434

Cn1c(-c2ccccc2)nc2c(Sc3ccc(F)cc3)ncnc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 9/20 0.55
ADORA2A P29274 9/20 0.55
ADORA1 P30542 9/20 0.55
ADORA2B P29275 7/20 0.55
PI4KA P42356 2/20 0.55
PI4K2B Q8TCG2 2/20 0.55
PI4K2A Q9BTU6 2/20 0.55
PI4KB Q9UBF8 2/20 0.55
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
MAPK13 O15264 2/20 0.38
GCGR P47871 2/20 0.38
MAPK12 P53778 2/20 0.38
MAPK11 Q15759 2/20 0.38
MAPK14 Q16539 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6660016 0.91 ADORA3 (0.62) ADORA3ADORA2AADORA1ADORA2BPI4KA
SCHEMBL6661208 0.89 MAPK13 (0.50) ADORA3ADORA2AADORA1ADORA2BPI4KA
SCHEMBL6660810 0.85 ADORA3 (0.52) ADORA3ADORA2AADORA1ADORA2BPI4KA
SCHEMBL6665550 0.84 ADORA3 (0.45) ADORA3ADORA2AADORA1ADORA2BPI4KA
SCHEMBL6660416 0.84 PTGS2 (0.46) ADORA3ADORA2AADORA1
SCHEMBL6660588 0.80 ADORA3 (0.60) ADORA3ADORA2AADORA1ADORA2BPI4KA
SCHEMBL6667230 0.79 ADORA3 (0.48) ADORA3ADORA2AADORA1ADORA2BPI4KA
SCHEMBL6663728 0.79 ADORA3 (0.48) ADORA3ADORA2AADORA1ADORA2BPI4KA
SCHEMBL6666272 0.74 ADORA2A (0.51) ADORA3ADORA2AADORA1ADORA2BPI4KA
SCHEMBL4066247 0.72 ADORA3 (0.57) ADORA3ADORA2AADORA1ADORA2BPI4KA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1444982-A1 The use of purine derivatives as selective kinase inhibitors MERCKLE GMBH (DE) 2004-08-11 EP disclosed